R. M. Nanau, L. E. Cohen, and M. G. Neuman, “Risk of Infections of Biological Therapies with Accent on Inflammatory Bowel Disease”, J Pharm Pharm Sci, vol. 17, no. 4, pp. 485–531, Oct. 2014.